In oral squamous cell carcinoma, NF-κB activation enhances M1 macrophage responses (36), whereas in lung and colorectal cancers, PTM-modulated NF-κB drives M2 TAM enrichment and links chronic inflammation to tumor progression (37–39). Here, NFKB1 is linked to colorectal cancer.